Use of novel oral anticoagulants in patients with end-stage renal disease
Hemodial Int
.
2015 Jan;19(1):150-3.
doi: 10.1111/hdi.12251.
Epub 2014 Dec 12.
Authors
Wolfgang C Winkelmayer
1
,
Charles A Herzog
,
Maria E Montez-Rath
,
Tara I Chang
,
Glenn M Chertow
Affiliation
1
Section of Nephrology, Baylor College of Medicine, Houston, Texas, USA; Division of Nephrology, Stanford University School of Medicine, Palo Alto, California, USA.
PMID:
25495752
DOI:
10.1111/hdi.12251
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Anticoagulants / administration & dosage
Anticoagulants / therapeutic use*
Humans
Renal Insufficiency, Chronic / drug therapy*
Substances
Anticoagulants
Grants and funding
R01DK095024/DK/NIDDK NIH HHS/United States